Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease

1

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease, affecting 30% of the global population.
2

Liver fibrosis is a critical prognostic factor in MASLD, associated with increased mortality and complications like cirrhosis and hepatocellular carcinoma.
3

Ultrasound-guided attenuation parameter (UGAP) and two-dimensional shear wave elastography (2D-SWE) are emerging noninvasive techniques for assessing hepatic steatosis and fibrosis.
4

This study aims to evaluate the performance and reproducibility of UGAP for quantifying hepatic steatosis in biopsy-proven MASLD patients.
5

Participants in the study underwent liver biopsy and ultrasound assessments, with strict inclusion and exclusion criteria to ensure reliable results.

European Radiology

by Roberto Cannella, Francesco Agnello, Giorgia Porrello, Alessandro Umberto Spinello, Giuseppe Infantino, Grazia Pennisi, Daniela Cabibi, Salvatore Petta, Tommaso Vincenzo Bartolotta
October 7, 2024

1